Phase I/II Study of MAK683 in Patients with Advanced Malignancies, Including Diffuse Large B-Cell Lymphoma
Ribrag, Vincent, Michot, Jean-Marie, Igleias, Lara, Tan, Daniel, Ma, Brigette, Duca, Matteo, Wainberg, Zev A., Fan, Yu Yun, Suenaga, Naoka, Cheng, Yi, Lai, Clinton, Yokota, Tomoya
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Pharmacokinetic and pharmacodynamic activity evaluation of MAK683, a selective oral embryonic ectoderm development (EED) inhibitor, in adults with advanced malignancies in a first-in-human study
Ribrag, Vincent, Wainberg, Zev A., Iglesias Docampo, Lara, Ramkumar, Thiruvamoor, Barys, Louise, Chen, Shuqi, Raccuglia, Marc, Wilbaux, Mélanie, Beltz, Karen, Luyt, Amy, Fan, Yu Yun, Suenaga, Naoko, Luo, Fangjun, Dai, Xuan, Lai, Clinton, Chen, Jia
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Significant response to pasireotide (SOM230) in the treatment of a patient with persistent, refractory Cushing's disease
Cukier, Kimberly, Tewari, Reena, Kurth, Fabian, Schmid, Herbert A., Lai, Clinton, Torpy, David J.
Published in Clinical endocrinology (Oxford) (01.08.2009)
Published in Clinical endocrinology (Oxford) (01.08.2009)
Get full text
Journal Article
Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL study
Kuo, Ching-Yuan, Wang, Po-Nan, Hwang, Wen-Li, Tzeng, Cheng-Hwai, Bai, Li-Yaun, Tang, Jih-Luh, Chang, Ming-Chih, Lin, Sheng-Fung, Chen, Tsai-Yun, Chen, Yeu-Chin, Tan, Tran-Der, Hsieh, Chih-Yi, Lin, Chinjune, Lai, Clinton, Miljkovic, Darko, Chang, Cheng-Shyong
Published in Therapeutic advances in hematology (01.03.2018)
Published in Therapeutic advances in hematology (01.03.2018)
Get full text
Journal Article